Publications and Further Research Outputs
Peer-Reviewed Publications
Fallon, P.G. and Lavin, M. and O'Donnell, J.S., SIPPET: insights into factor VIII immunogenicity, Journal of Thrombosis and Haemostasis, 16, (1), 2018, p36-38
Mcdonnell, C.J. and Soule, E.E. and Walsh, P.T. and O'donnell, J.S. and Preston, R.J.S., The Immunoregulatory Activities of Activated Protein C in Inflammatory Disease, Seminars in Thrombosis and Hemostasis, 2018, p167 - 175
Lavin, M. and Ryan, K. and White, B. and Byrne, M. and O'Connell, N.M. and O'Donnell, J.S., A role for intravenous immunoglobulin in the treatment of Acquired Von Willebrand Syndrome associated with IgM gammopathy, Haemophilia, 2017, pe22-e25
Brophy, T.M. and Ward, S.E. and McGimsey, T.R. and Schneppenheim, S. and Drakeford, C. and O'Sullivan, J.M. and Chion, A. and Budde, U. and O'Donnell, J.S., Plasmin cleaves von willebrand factor at K1491-R1492 in the A1-A2 linker region in a shear- and glycan-dependent manner in vitro, Arteriosclerosis, Thrombosis, and Vascular Biology, 37, (5), 2017, p845-855
Gleeson, E.M. and McDonnell, C.J. and Soule, E.E. and Willis Fox, O. and Rushe, H. and Rehill, A. and Smith, O.P. and O'Donnell, J.S. and Preston, R.J.S., A novel protein Câ"factor VII chimera provides new insights into the structural requirements for cytoprotective protease-activated receptor 1 signaling, Journal of Thrombosis and Haemostasis, 15, (11), 2017, p2198-2207
Tobin WO, Kinsella JA, Kavanagh GF, O'Donnell JS, McGrath RT, Tierney S, Egan B, Feeley TM, Coughlan T, Collins DR, O'Neill D, Murphy SJ, Lim SJ, Murphy RP, McCabe DJH, Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypes., J Neurol Sci, 375, 2017, p404 - 410
O'sullivan, J.M. and Preston, R.J.S. and Robson, T. and O'donnell, J.S., Emerging Roles for von Willebrand Factor in Cancer Cell Biology, Seminars in Thrombosis and Hemostasis, 2017
Lavin, M. and Jenkins, P.V. and Keenan, C. and White, B. and Betts, D.R. and O'Donnell, J.S. and O'Connell, N.M., X-linked moyamoya syndrome associated with severe haemophilia A, Haemophilia, 22, (1), 2016, pe51-e54
O'regan, N. and Gegenbauer, K. and O'sullivan, J.M. and Maleki, S. and Brophy, T.M. and Dalton, N. and Chion, A. and Fallon, P.G. and Grau, G.E. and Budde, U. and Smith, O.P. and Craig, A.G. and Preston, R.J.S. and O'Donnell, J.S., A novel role for von Willebrand factor in the pathogenesis of experimental cerebral malaria, Blood, 127, (9), 2016, p1192-1201
Lavin M, Brophy T.M, Rawley O, O'Sullivan J.M, Hayden P.J, Browne P.V, Ryan K, O'Connell N, O'Donnell J.S, Lenalidomide as a novel treatment for refractory acquired von Willebrand syndrome associated with monoclonal gammopathy, Journal of Thrombosis and Haemostasis, 14, (6), 2016, p1200 - 1205
O'Sullivan, J.M. and Jenkins, P.V. and Rawley, O. and Gegenbauer, K. and Chion, A. and Lavin, M. and Byrne, B. and O'Kennedy, R. and Preston, R.J.S. and Brophy, T.M. and O'Donnell, J.S., Galectin-1 and galectin-3 constitute novel-binding partners for Factor VIII, Arteriosclerosis, Thrombosis, and Vascular Biology, 36, (5), 2016, p855-863
Fischer, K. and Iorio, A. and Hollingsworth, R. and Makris, M. and Watson, H. and Rae, J. and Platokouki, H. and Pergantou, H. and Katsarou, O. and Theodossiades, G. and Nomikou, E. and Parra, R. and Alonso, S. and Klamroth, R. and Kubicek, C. and Wilde, J. and Dunkley, T. and Oldenburg, J. and Schmickler, D. and Ackroyd, S. and Mirza, L. and Batorova, A. and Jankovicova, D. and Auerswald, G. and Buehrlen, M. and Penka, M. and Smejkal, P. and Blatny, J. and Zapletal, O. and Hermans, C. and Lambert, C. and Tagariello, G. and Radossi, P. and Nolan, B. and Brady, B. and O'Donnell, J. and Singleton, E. and Thomas, A. and Shea, I. and Morfini, M. and Linari, S. and de Moerloose, P. and Boehlen, F. and Campbell Tait, R. and Brodie, N. and Chalmers, E. and Gibson, A. and Meijer, K. and Tamminga, R. and Lassila, R. and Armstrong, E. and Zulfikar, B. and Ozdemir, N. and Kavakli, K. and Balkan, C. and Jurgutis, R. and Gailiute, N. and Peerlinck, K. and Geet, C.V. and Goudemand, J. and Wibaut, B. and Diniz, M.J. and Antunes, M. and Liesner, R. and Khair, K. and Laffan, M. and Patel, S. and Thynn Yee, T. and Harrington, C. and Pasi, J. and Bowles, L. and Bevan, D. and Madan, B. and Negrier, C. and Ringenbach, S. and Mingot Castellano, M.E. and Astermark, J. and Lindvall, K. and Gatt, A. and Hay, C.R.M. and Grey, P. and Will, A. and Hague, A. and Peyvandi, F. and Mancuso, M.E. and Schved, J.F. and Rousseau, F. and Kurnik, K. and Bidlingmaier, C. and Rocino, A. and Hanley, J. and Talks, K. and Antoniades, M. and Zanon, E. and Bon, E.D. and Lambert, T. and Rothschild, C. and Matingou, M. and Tagliaferri, A. and Rivolta, G.F. and Iorio, A. and Marchesini, E. and Fraga, C. and Cunha-Ribeiro, L. and Carvalho, M. and Komrska, V. and Pindurova, E. and Lejniece, S. and Kluce, G. and Leebeek, F. and Cnossen, M. and Makris, M. and Lockley, C. and Payne, J. and Vidler, V. and Lissitchkov, T. and Raia, P. and Holmstre om, M. and Garipidou, V. and Vakalopoulou, S. and Serban, M. and Mihailov, M.-D. and Schinco, P. and Valeri, F. and Schutgens, R. and Bonanad, S. and Cid, A.R. and Castaman, G. and Pabinger, I. and Reitter, S.-E. and Male, C. and Thom, K. and Windyga, J. and Piorowski, M. and Schmugge, M. and Albisetti, M., FVIII inhibitor development according to concentrate: Data from the EUHASS registry excluding overlap with other studies, Haemophilia, 22, (1), 2016, pe36-e38
O'Sullivan J., O'Sullivan J., Aguila S., Aguila S., McRae E., Ward S., Ward S., Rawley O., Fallon P., Brophy T., Brophy T., Preston R., Preston R., Brady L., Sheils O., Chion A., Chion A., O'Donnell J., O'Donnell J., O'Donnell J., N-linked glycan truncation causes enhanced clearance of plasma-derived von Willebrand factor, Journal of Thrombosis and Haemostasis, 14, (12), 2016, p2446-2457
Collins, P. and Chalmers, E. and Chowdary, P. and Keeling, D. and Mathias, M. and O'Donnell, J. and Pasi, K.J. and Rangarajan, S. and Thomas, A., The use of enhanced half-life coagulation factor concentrates in routine clinical practice: guidance from UKHCDO, Haemophilia, 22, (4), 2016, p487-498
Chion A, O'Sullivan JM, Drakeford C, Bergsson G, Dalton N, Aguila S, Ward S, Fallon PG, Brophy TM, Preston RJ, Brady L, Sheils O, Laffan M, McKinnon TA, O'Donnell JS., N-linked glycans within the A2 domain of von Willebrand factor modulate macrophage-mediated clearance., Blood, 128, (15), 2016, p1959-1968
Lavin, M. and O'Donnell, J.S., New treatment approaches to von Willebrand disease, Hematology, 2016, (1), 2016, p683-689
Lavin, M. and Kavanagh, J. and Beddy, P. and O'Connell, N.M. and O'Donnell, J.S., Recurrent lower limb venous thrombosis associated with a congenitally absent infrarenal inferior vena cava, QJM, 109, (1), 2016, p57
O'Sullivan, J.M. and Preston, R.J.S. and O'Regan, N. and O'Donnell, J.S., Emerging roles for hemostatic dysfunction in malaria pathogenesis, Blood, 127, (19), 2016, p2281-2288
Lavin, M. and Jenkins, P.V. and Healy, M.L. and Byrne, M. and O'Connell, N.M. and O'Donnell, J.S., Age-related factor IX correction in symptomatic female carriers with haemophilia B Leyden, Haemophilia, 21, (6), 2015, pe498-e500
Quinn, L.M. and Drakeford, C. and O'Donnell, J.S. and Preston, R.J.S., Engineering activated protein C to maximize therapeutic efficacy, Biochemical Society Transactions, 43, 2015, p691-695
Kinsella JA, Tobin WO, Kavanagh GF, O'Donnell JS, McGrath RT, Tierney S, Feeley TM, Egan B, O'Neill D, Collins DR, Coughlan T, Harbison JA, Doherty CP, Madhavan P, Moore DJ, O'Neill SM, Colgan MP, Saqqur M, Murphy RP, Moran N, Hamilton G, McCabe DJ, Increased thrombin generation potential in symptomatic versus asymptomatic moderate or severe carotid stenosis and relationship with cerebral microemboli., Journal of Neurology, Neurosurgery, and Psychiatry, 86, 2015, p460-467
Rawley, O. and O'Sullivan, J.M. and Chion, A. and Keyes, S. and Lavin, M. and van Rooijen, N. and Brophy, T.M. and Fallon, P. and Preston, R.J.S. and O'Donnell, J.S., von Willebrand factor arginine 1205 substitution results in accelerated macrophage-dependent clearance in vivo, Journal of Thrombosis and Haemostasis, 13, (5), 2015, p821-826
Gleeson EM, Dichiara MG, Salicio A, Quinn LM, Drakeford C, Russell SE, Walsh PT, Orbe J, Hermida J, Smith OP, O'Donnell JS, Montes R, Preston RJ., Activated protein C β-glycoform promotes enhanced noncanonical PAR1 proteolysis and superior resistance to ischemic injury., Blood, 126, (7), 2015, p915 - 919
Gleeson, E.M. and O'Donnell, J.S. and Hams, E. and à inle, F.N. and Kenny, B.-A. and Fallon, P.G. and Preston, R.J.S., Activated factor x signaling via protease-activated receptor 2 suppresses pro-inflammatory cytokine production from lipopolysaccharide-stimulated myeloid cells, Haematologica, 99, (1), 2014, p185-193
Laffan M, Lester W, O'Donnell JS, Will A, Tait RC, Goodeve A, Millar CM, Keeling D , Diagnosis and management of von Willebrand disease: A United Kingdom Haemophilia Centre Doctors Organisation guideline approved by the British Committee for Standards in Haematology., British Journal of Haematology, 2014
Tobin WO, Kinsella JA, Kavanagh GF, O'Donnell JS, McGrath RT, Tierney S, Egan B, Feeley TM, Coughlan T, Collins DR, Harbison JA, McCabe DJH, Longitudinal assessment of von Willebrand factor antigen and von Willebrand factor propeptide in response to alteration of antiplatelet therapy after TIA or ischaemic stroke., Journal of Neurology, 261, (7), 2014, p1405 - 1412
Gleason E, O'Donnell JS, Hams E, Fallon PF, Preston RJ. , Activated Factor X Inhibits Leukocyte Pro-inflammatory Cytokine Release upon Toll-like Receptor Stimulation. , Haematologica, 99, (1), 2014, p185 - 193
Kinsella JA, Tobin WO, Kavanagh GF, O'Donnell JS, McGrath RT, Tierney S, Feeley TM, Egan B, O'Neill D, Collins RD, Coughlan T, Harbison JA, Doherty CP, Madhavan P, Moore DJ, O'Neill SM, Colgan MP, Saqqur M, Murphy RP, Moran N, Hamilton G, McCabe DJ, Increased endothelial activation in recently symptomatic versus asymptomatic carotid artery stenosis and in cerebral microembolic-signal-negative patient subgroups., European Journal of Neurology, 2014, p460-467
Laffan, M.A. and Lester, W. and O'Donnell, J.S. and Will, A. and Tait, R.C. and Goodeve, A. and Millar, C.M. and Keeling, D.M. and Dolan, G., The diagnosis and management of von Willebrand disease: A United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology, British Journal of Haematology, 167, (4), 2014, p453-465
Matino D, Lillicrap D, Astermark J, Dolan G, Kessler C, Lambert T, Makris M, O'Donnell JS, Pipe S, Santagostino E, Saint-Remy, Iorio A., Switching clotting factor concentrates: Considerations in estimating the risk of immunogenicity., Haemophilia, 20, (2), 2014, p200 - 206
Tobin WO, Kinsella JA, Kavanagh GF, O'Donnell JS, McGrath RA, Collins DR, Coughlan T, O'Neill D, Egan B, Tierney S, Feeley TM, Murphy RP, McCabe DJ, Longitudinal assessment of thrombin generation potential in response to alteration of antiplatelet therapy after TIA or ischaemic stroke., Journal of Neurology, 260, (2), 2013, p590-6
Harris LF, Rainey P, Castro-López V, O'Donnell JS, Killard AJ. , A microfluidic anti-Factor Xa assay device for point-of-care monitoring of anticoagulation therapy. , Analyst, 138, (17), 2013, p4769 - 4776
McGrath RT, van den Biggelaar M, Byrne B, O'Sullivan JM, Rawley O, O'Kennedy R, Voorberg J, Preston RJ, O'Donnell JS. , Altered glycosylation of platelet-derived von Willebrand factor confers resistance to ADAMTS13 proteolysis. , Blood, 122, (25), 2013, p4107 - 4110
Tilley DO, Albert MA, Smolenski A, Cox D, O'Donnell JS, Douglas CW, Watson SP, Kerrigan SW., Glycoprotein Ib and FcRIIa play key roles in platelet activation by the colonizing bacterium, Streptococcus oralis, Journal of Thrombosis and Haemostasis, 11, (5), 2013, p941 - 950
Berntorp E, Fuchs B, Makris M, Montgomery RR, Flood VH, O'Donnell JS, Federici A, Lillicrap D, James P, Budde U, Morfini M, Petrini P, Austin S, Kannicht C, Lee C. , Third Åland island conference on von Willebrand disease, Haemophilia, (Supp 3), 2013, p1 - 18
Preston RJ, Rawley O, Gleeson EM, O'Donnell JS, Elucidating the role of carbohydrate determinants in regulating hemostasis: insights and opportunities., Blood, 121, (19), 2013, p3801 - 3810
Gleason EM, O'Donnell JS, Preston RJ. , The Endothelial Cell Protein C receptor: cell surface conductor of cytoprotective coagulation factor signaling. , Cellular and Molecular Life Sciences, 69, (5), 2012, p717 - 726
Jenkins PV, Rawley O, Smith OP, O'Donnell JS, Elevated factor VIII levels and risk of venous thromboembolism., British Journal of Haematology, 157, (6), 2012, p653 - 663
Jenkins PV, Keenan C, Keeney S, Cumming T, O'Donnell JS, Clinical utility gene card for: haemophilia B., European Journal of Human Genetics, 20, (5), 2012, p268 - 271
O'Donnell D, O'Connell N, O'Donnell JS, Einstein-PE study should not affect VTE therapy for cancer patients., New England Journal of Medicine, 366, (26), 2012, p2525-
Ryan K, O'Donnell JS, Elevated plasma factor VIII levels in patients with venous thrombosis - Constitutional risk factor or secondary epiphenomenon?, Thrombosis Research, 129, (2), 2012, p105 - 106
Castro-Lopez V, Harris LF, O'Donnell JS and Killard AJ, Comparative study of Factor Xa fluorogenic substrates and their influence on the quantification of LMWHs, Analytical and Bioanalytical Chemistry, 399, 2011, p691 - 700
Cumming AM, Keeney S, Jenkins PV, Nash MJ, O'Donnell JS, Clinical utility gene card for: von Willebrand disease, European Journal of Human Genetics, Jan 5, 2011, pEpub-
Castro-López V, Murray B, Harris LF, O'Donnell JS, Killard AJ, Effects of four commercially available factor Xa proteins on the fluorogenic anti-factor Xa assay when monitoring unfractionated heparin., Blood Coagulation & Fibrinolysis : An International Journal in Haemostasis and Thrombosis, 2011
Harris LF, O'Brien A, Castro-López V, O'Donnell JS, Killard AJ. , Comparison of the anticoagulant response of a novel fluorogenic anti-FXa assay with two commercial anti-FXa chromogenic assays., Thrombosis Research, , 128, (6), 2011, p125 - 129
Bacon CL, Singleton E, Brady B, White B, Nolan B, Gilmore R, O'Donnell JS. , Low risk of inhibitor formation in haemophilia A patients following an en masse switch in treatment to a third generation full length recombinant FVIII product. , Haemophilia, 17, (3), 2011, p407 - 411
Harris LF, Castro-López V, Jenkins PV, O'Donnell JS, Killard AJ. , Comparison of a fluorogenic anti-FXa assay with a central laboratory chromogenic anti-FXa assay for measuring LMWH activity in patient plasmas., Thrombosis Research, 128, (6), 2011, p166 - 170
Ni Ainle F*, O'Donnell JS* (joint first author), Johnson J, Gleeson E, Smith OP, Preston RJ. , Activated protein C N-linked glycans regulate cytoprotective signalling on endothelial cells, Journal of Biological Chemistry, 286, (2), 2011, p1323 - 1330
Keeney S, Cumming AM, Nash MJ, O'Donnell JS, Jenkins PV. , Clinical utility gene card for: Haemophilia A., European Journal of Human Genetics,, 19, (11), 2011, p107 - 111
Vanessa Castro-Lopez, Leanne F. Harris, James S. O'Donnell, Anthony J. Killard, Quantification of unfractionated heparin in human plasma and whole blood by means of novel fluorogenic anti-FXa assays, Journal of Pharmaceutical and Biomedical Analysis, 56, (5), 2011, p992-997
Harris LF, Castro-López V, Jenkins PV, O'Donnell JS, Killard AJ. , Comparison of a fluorogenic anti-FXa assay with a central laboratory chromogenic anti-FXa assay for measuring LMWH activity in patient plasmas., Thrombosis Research, 128, (6), 2011, p166 - 170
McLean S, Ryan M, O'Donnell JS, Role of primary thromboprophylaxis in the palliative care setting - a systematic review, Palliative Medicine, 24, (4), 2010, p386 - 395
McGrath R, McKinnon TA, Byrne B, O'Kennedy R, McRae E, Preston RJ, O'Donnell JS, Terminal 2-6 linked sialic acid expression determines VWF proteolysis by ADAMTS13, Blood, 115, (13), 2010, p2666 - 2673
Terraube V, O'Donnell JS, Jenkins PV, Factor VIII and von Willebrand interactions - biochemical basis and physiological significance, Haemophilia, 16, (1), 2010, p3 - 13
Gilmore R, Harmon S, Gannon C, O'Donnell JS, Jenkins PV, Thrombin generation in haemophilia A patients with factor VIII assay discrepancy, Haemophilia, 16, (4), 2010, p671 - 674
Bridges DJ, Bunn J, van Mourik J, Preston RJ, Molyneux M, Combes V, O'Donnell JS, de Laat B, Craig A. , Rapid activation of endothelial cells enables P. falciparum adhesion to platelet decorated von Willebrand factor strings, Blood, 115, (7), 2010, p1472 - 1474
McGrath R, McRae E, Smith OP, O'Donnell JS, Platelet VWF - structure, function and biological significance, British Journal of Haematology, 148, (6), 2010, p834 - 843
Byrne M, Reynolds JV, O'Donnell JS, Keogan M, White B, Murphy S, Maher S, Pidgeon G, Activation of the procoagulant response following neoadjuvant chemotherapy and radiation therapy, and long-term activation following major cancer surgery, British Journal of Cancer, 102, (1), 2010, p73 - 79
Sherlock E, O'Donnell JS, White B, Blake C , Physical activity levels and participation in sport in Irish people with haemophilia, Haemophilia, 16, (1), 2010, pe202 - e209
Harris L, Castro-López V, Hammadi N, O'Donnell JS, Killard AJ, The development of a fluorescent anti-factor Xa (FXa) assay and its application to the monitoring of a range of heparin-like anticoagulants, Talanta, 81, (4-5), 2010, p1725 - 1730
Byrne M, Reynolds JV, O'Donnell JS, Keogan M, White B, Byrne M, Murphy S, Maher SG, Pidgeon GP, Long-term activation of the pro-coagulant response after neoadjuvant chemoradiation and major cancer surgery., British Journal of Cancer, 102, (1), 2010, p73-9
Ni Ainle F, Preston RJ, Jenkins PV, Johnson JS, Nell H, Fallon PG, White B, O'Donnell JS. , Protamine sulphate downregulates thrombin generation by inhibiting factor V activation, Blood, 114, (8), 2009, p1658 - 1665
Cunningham MS, Preston RJ, and O'Donnell JS. , Does antithrombotic therapy improve survival in cancer patients?, Blood Reviews, 23, 2009, p129 - 135
Preston, RJ, Tran, S, Johnson, JA, Ainle, FN, Harmon, S, White, B, Smith, OP, Jenkins, PV, Dahlbäck, B, O'Donnell, JS, Platelet factor 4 impairs the anticoagulant activity of activated protein C., The Journal of Biological Chemistry, 284, (9), 2009, p5869 - 5875
Preston RJ, Morse, Cutler, Murden, Brady SK, O'Donnell JS, Mumford AD. , Pseudo-homozygous protein C deficiency due to co-inheritance of novel type I and type IIb protein C variants., British Journal of Haematology, 144, (6), 2009, p946 - 953
Gilmore R, Harmon S, Keane G, Gannon C and O'Donnell JS , Variation in anticoagulant composition regulates differential effects of prothrombin complex concentrates on TF-initiated thrombin generation, Journal Thrombosis Haemostasis, 7, (12), 2009, p2154 - 2156
Larkin, D, de Laat, B, Jenkins, PV, Bunn, J, Craig, AG, Terraube, V, Preston, RJ, Donkor, C, Grau, GE, van Mourik, JA, O'Donnell, JS, Severe Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibition., PLoS Pathogens, 5, (3), 2009, p1 - 8
Ní Áinle F, Wong A, Appleby N, Byrne B, O Sullivan A, White B, O'Donnell J. , Efficacy and safety of once daily low molecular weight heparin (Tinzaparin sodium) in high risk pregnancy., Blood Coagulation and Fibrinolysis,, 19, 2008, p689 - 692
Gilmore R, Doyle M, Holden F and O'Donnell J, Activated protein C resistance, factor V Leiden and assessment of thrombotic risk, Irish Medical Journal, 101, (8), 2008, p256 - 257
Hochart H, Jenkins PV, Preston RJ, Smith OP, White B, O'Donnell JS, Concentration-dependent roles for heparin in modifying LPS-induced activation of mononuclear cells in whole blood., Thrombosis and Haemostasis, 99, 2008, p570 - 575
Cunningham SM, Gilmore R, O'Donnell D, O'Donnell JS., Management of refractory venous thrombosis associated with malignancy using a supra-therapeutic Enoxaparin regimen. , Irish Journal of Medical Science,, 1, 2008, pe1 - e3
Jenkins PV, Egan H, Keenan C, Mellars G; O'Shea E, Nolan B, White B, O'Donnell J., Factor IX mutations and Haemophilia B in the Irish Population: Distinct genetic mechanisms for severe and mild haemophilia B., Haemophilia , 14, 2008, p717 - 722
Winter PC, Egan H, McNulty O, Jones FG, O'Donnell J, Jenkins PV, Recurrent F8 Mutation in Irish Haemophilia A Patients: Evidence for a Founder Effect., Haemophilia, 14, 2008, p394 - 395
Harmon, S, Preston, RJ, Ainle, FN, Johnson, JA, Cunningham, MS, Smith, OP, White, B, O'Donnell, JS, Dissociation of activated protein C functions by elimination of protein S cofactor enhancement., The Journal of Biological Chemistry, 283, (45), 2008, p30531 - 30539
Loscertales MP, Owens S, O'Donnell JS, Bunn J, Brabin BJ., ABO blood group phenotypes and falciparum malaria: unlocking a pivotal mechanism., Advances in Parasitology, 65, 2007, p1 - 50
Jenkins PV and O'Donnell JS., ABO blood group determines plasma von Willebrand factor levels - a biological function after all?, Transfusion, 46, 2006, p1836 - 1844
Hollestelle MKJ, Donkor C, Mantey E, Craig A, Akoto J, O'Donnell J, van Mourik J, Bunn J. , Von Willebrand factor propeptide in severe malaria: evidence of acute endothelial cell activation. , British Journal of Haematology, 133, 2006, p562 - 569
Cunningham SE, White B, Hollywood D, and O'Donnell JS., Primary thromboprophylaxis for cancer patients with central venous catheters - a reappraisal of the evidence., British Journal of Cancer, 94, 2006, p189 - 194
Cunningham SE, White B, and O'Donnell JS., Prevention and management of venous thrombo-embolism in patients with cancer - a review of the evidence., Clinical Oncology, 1, 2006, p145 - 151
O'Donnell JS, Hinkson L, McCarthy A, Manning R, Khan A, and Lafffan MA, Antithrombin Nagasaki (Ser 116 to Pro): a rare antithrombin variant with abnormal heparin binding presenting during pregnancy., Blood Coagulation and Fibrinolysis, 17, 2006, p217 - 220
O'Donnell J. , Prevention of hospital acquired venous thromboembolism., British Medical Journal Learning., 1, 2005, p1 - 5
Crawley JTB, Lam JK, Rance JB, Mollica LR, O'Donnell JS and Lane DA., Proteolytic Regulation of ADAMTS-13: Novel Roles for Thrombin and Plasmin., Blood, 105, 2005, p1085 - 1093
O'Donnell JS., Severe factor V deficiency and pregnancy - a role for solvent-detergent plasma? , Haemophilia, 11, 2005, p422 - 423
Cunningham N, Laffan MA, Manning RA and O'Donnell J. , Role of Low-Density Lipoprotein Receptor-Related Protein (LRP) in Patients with Elevated FVIII:C and Venous Thrombosis., Blood Coagulation and Fibrinolysis, , 16, 2005, p465 - 468
O'Donnell JS, McKinnon TAJ, Crawley JTB, Lane DA and Laffan MA., Bombay phenotype is associated with reduced plasma VWF levels and an increased susceptibility to ADAMTS13 proteolysis., Blood, 106, 2005, p1988 - 1991
O'Donnell J, Riddell A, Owens D, Pasi KJ and Perry DJ., Role of the Thromboelastograph as an adjunctive test in thrombophilia screening., Blood Coagulation and Fibrinolysis , 15, 2004, p207 - 211
Baguley C, Guri S, O'Donnell J, and Howard D., Consumptive coagulopathy complicating juvenile angiofibroma. , Journal of Laryngology and Otology,, 118, 2004, p835 - 839
O'Connell MP, Murphy KM, White B and O'Donnell J., Solvent-detergent plasma as replacement therapy in a pregnant patient with factor V deficiency., Journal of Maternal Fetal and Neonatal Medicine, 16, 2004, p69 - 70
O'Donnell J, Manning RA, and Laffan M., Beta-adrenergic receptor polymorphisms in patients with elevated FVIII levels with venous thrombosis., British Journal of Haematology, 123, 2003, p139 - 141
O'Brien P, Murphy K, and O'Donnell J. , Acquired protein S deficiency in TTP patients receiving solvent / detergent plasma exchange. , British Journal of Haematology, 122, 2003, p518 - 519
O'Donnell J, and Laffan M. , Dissociation of ABH antigen expression from von Willebrand factor synthesis in endothelial cell lines., British Journal of Haematology , 121, 2003, p928 - 931
Doyle S, O'Brien P, Murphy K, and O'Donnell J. , Coagulation factor content of solvent / detergent plasma compared to fresh frozen plasma., Blood Coagulation and Fibrinolysis, 14, 2003, p283 - 287
O'Donnell J, Boulton FE, Manning RA, and Laffan M., Genotype at the Secretor blood group locus is a determinant of plasma von Willebrand factor level., British Journal of Haematology, 116, 2002, p350 - 356
Mumford AD, Laffan MA, O'Donnell J, McVey JH, Manning RA, and Kemball-Cook G., A Tyr346Cys substitution in the inter-domain acidic region a1 of Factor VIII in an individual with Factor VIII:C assay discrepancy. , British Journal of Haematology, 118, 2002, p589 - 594
O'Donnell J and Perry DJ., Pharmacotherapy of hyperhomocysteinaemia in patients with thrombophilia., Expert Opinion on Pharmacotherapy, 3, 2002, p1591 - 1598
O'Donnell J, Boulton FE, Manning RA, and Laffan M., The amount of H antigen expressed on circulating vWF is modified by ABO blood group genotype and is a major determinant of plasma vWF:Ag levels. , Arteriosclerosis, Thrombosis and Vascular Biology, 22, 2002, p335 - 341
O'Donnell J, Manning RA and Laffan M., The relationship between plasma concentration of a2-macroglobulin and ABO blood group., Thrombosis and Haemostasis, 88, 2002, p167 - 168
O'Donnell J, Mumford AD, Manning RA and Laffan MA. , Marked elevation of thrombin generation in patients with elevated FVIII:C and venous thromboembolism., British Journal of Haematology, 115, 2001, p687 - 697
O'Donnell J and Laffan M, Elevated plasma factor VIII:C - a novel independent risk factor for venous thromboembolism. , Clinical Laboratory , 47, 2001, p1 - 6
O'Donnell J and Laffan M, The relationship between ABO histo-blood group, factor VIII and von Willebrand factor. , Transfusion Medicine, 11, 2001, p1 - 10
Mumford A, O'Donnell J, Gillmore J, Manning R, and Laffan M. , Bleeding symptoms and coagulation test abnormalities in 337 patients with AL amyloidosis., British Journal of Haematology, 110, 2000, p454 - 460
O'Donnell J, Mille-Baker B and Laffan M, Human umbilical vein endothelial cells differ from other endothelial cells in failing to express ABO blood group antigens., Journal of Vascular Research, 37, 2000, p540 - 547
O'Donnell J, Mumford AD, Manning RA and Laffan M. , Elevation of FVIII:C in venous thromboembolism is persistent and independent of the acute phase response., Thrombosis and Haemostasis, 83, 2000, p10 - 13
O'Donnell J and Laffan M, Factor VIII and thrombosis, CME Bulletin Haematology, 2, 1999, p44 - 46
O'Donnell J, Goldman JM, Wagner K, Ehinger G, and Roberts I. , Donor-derived plasmodium vivax infection following volunteer unrelated bone marrow transplantation., Bone Marrow Transplantation, (21), 1998, p313 - 314
O'Donnell J, Tuddenham E, Manning R, Kemball-Cook G, and Laffan M. , High prevalence of elevated Factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction., Thrombosis and Haemostasis, 77, 1997, p825 - 828
O'Donnell J, Roberts I, Daly P, New H and Dokal I., Successful second bone marrow transplant for Fanconi's anaemia following escalation of conditioning., British Journal of Haematology, 98, 1997, p772 - 774
Research Expertise
Recognition
Awards and Honours
MRC Clinical Training Fellowship Award
Race Sanger Award - British Blood Transfusion Society
BHF Intermediate Fellowship Award
SFI President of Ireland Researcher Award
Memberships
International Society for Thrombosis and Haemostasis
American Society for Hematology
British Society of Haematology
British Society for Haemostasis and Thrombosis
Irish Haematology Association